Trade Abbott Laboratories - ABT CFD

Trading Conditions
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
Overnight funding adjustment
Charges from full value of position
-0.026262 %

Trade size with leverage ~ $5,000.00

Short position overnight funding adjustment ~ $4,000.00

Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
Overnight funding adjustment
Charges from full value of position
0.00404 %

Trade size with leverage ~ $5,000.00

Short position overnight funding adjustment ~ $4,000.00

Overnight funding adjustment time21:00 (UTC)
Min traded quantity1
Stock exchangeUnited States of America
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close104.12
1-Year Change-2.66%
Day's Range104.14 - 104.81

Abbott Company profile

What is Abbott Laboratories?

Abbott Laboratories is a US healthcare company that employs around 99,000 people and delivers its services in over 150 countries worldwide. Abbott produces and distributes a range of products under such popular brands as PediaSure, Glucerna, Similac, Absorb and others. Its mission statement is: “To improve lives by providing cost-effective health care products and services.”

The company focuses on the following healthcare segments: Nutrition, Vascular Care, Diabetes Care, Vision, Pharmaceuticals and Diagnostics. It advocates for innovation in medicine and works to improve vision correction, take heart health treatments to the next level and introduce innovative methods of diabetes management. 

Abbott has also pioneered new ways to screen, diagnose and monitor a wide range of health conditions with greater speed and accuracy. In pharmaceuticals, the company has revolutionised packaging and delivery to meet regional needs and offer access to medicines in areas that once lacked them.

Who are the key people at Abbott Laboratories?

Miles D. White is Chairman and Chief Executive Officer of Abbott. He has held both roles since 1999, and first joined the company back in 1984. Another key figure at Abbott Laboratories is Brian Blaser, Executive Vice President, Diagnostics Products. He leads Abbott's diagnostics, molecular and point-of-care businesses. Robert Ford is Executive Vice President, Medical Devices. 

What is the modern history of Abbott Laboratories?

Abbott was incorporated in 1894, and its initial public offering took place in 1929. Among a number of landmark developments in the second half of the 20th century was the acquisition of M&R Dietetics in 1964, which made the company a leader in nutrition. Abbott’s modern diagnostics business took off in the early 1970s, and in 1985 the FDA approved the firm’s test to identify HIV in blood. In 1998 Abbott introduced Glucerna – a range of snack bars and shakes for diabetics. The first decade of the 21st century saw FDA approval of antibody drug Humira, which became the world’s leading pharmaceutical product.

What are the latest developments at Abbott Laboratories?

In January 2017 Abbott completed the acquisition of St Jude Medical – a development which put the company in a leading position in the medical devices sector. Abbott now holds the No.1 or No.2 positions in nearly every segment of the $30 billion cardiovascular market. In 2017 Abbott also recorded 40 per cent growth in its neuromodulation business, attaining the No.1 spot in spinal cord neurostimulation.

In February 2018, Abbott announced a licensing deal with mid-tech firm Surmodics Inc that could be worth up to $92 million. Under the agreement, Surmodics will exclusively license its SurVeil drug-coated balloon device to Abbott. Surmodics is testing it as a treatment for peripheral artery disease.

Since the start of 2015, the Abbott share price has ranged from a low of around $37 in February 2016 to over $60 in January 2018. The company’s market capitalisation on 2 March 2018 was $103.5 billion. Our ABT chart tracks Abbott’s recent share price movements.

Where does Abbott Laboratories operate?

Abbott is headquartered in Chicago, Illinois. It has a truly global presence, with operations across the Americas, Europe and Asia Pacific – including China, India, Japan, Australia and New Zealand.

Where is Abbott Laboratories traded?

Abbott Laboratories is listed on the New York Stock Exchange. As of 2017, the shares were mainly held by institutional investors such as BlackRock, State Street Corporation and The Vanguard Group. Check out for the latest ABT chart.

Latest shares articles

Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
13:59, 8 July 2024
FOMC preview: Still expecting three rate cuts in 2024?
The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?
08:30, 11 June 2024
3 UK Stocks to Watch
Let’s take a look at three FTSE 100 heavyweights demonstrating high levels of relative strength.
12:41, 3 June 2024
Brilliant Basics - Part 2: Reversal Zones
Welcome to the second part of our educational series, Brilliant Basics. In this series, we'll explore how mastering the fundamentals lays the groundwork for achieving high-level performance in trading. Today, we focus on reversal zones, specifically the art of drawing support and resistance consistently across multiple timeframes.
11:17, 29 May 2024

Read our reviews to find out more about us

Read the feedback from our clients, whatever their experience level.

the simplicity and the pros of this app makes it amazing and a useful app


I have already tested many brokers and I can definitely say that is the most professional trading tool.

PaCeKw is a good broker. I haven't had any problems with the trading platform but i qould advise that they add an option for either using lots or units.


I am in the first time but I look this website in YouTube there's a very good and safe platform for a traders Thinks for taking my opinion


great UI, simple platform, low spreads, great coverage

Jihad Kattar

The videos are easy to follow, i get my profits and downs and understand the market now even more. This app is very well to understand. I would recommend this app to friends if they want to know.


Good and amazing app for trading and easy setups easy and smooth buy and sell amazing


Excellent for people who would like to get and build all the experience needed to navigate to Stock Market.


Overall my experience is very good with capital, the one best thing is they give you call support with most other broker apps don’t gives.


I have been usingCapital.comm platform for a year now. I did have some issues with using the platform in the earlier days but I received excellent support from guiding me in the process of learning about the platform and put me on track. I am very happy with this platform and find it very easy to use for my trading needs. also arranged a series of trading webinars last summer, which I attended and benefited from.

Dr Anjum Pervez

The best app for trade ever I tried to much trade app and this is the best


Great website, easy to use and user friendly. Lot of markets to trade with. Good database of information and learning tutorials for beginner. Great customer support. I had some issues and they helped me solve them rapidly. One of the best broker, I recommend.

Nicolas Crampet

Trusted trading Platform is the most trusted trading platform I ever experienced. Even without taking any demo,I have started funding and it’s going well. It is a very easy platform for the beginners and can have better trading experience by using this


great app, love the weekly and monthly insights, and review they send about my trading habits. spread for gold is usually 0.3 but at times fluctuates up to 0.9 this often makes it hard trading on the low time frames and not losing my position to spread even if my bias was correct, if the spread was better I'd give 5 star.

chris hoeben is the best broker of all time and I Should give it five stars but there is a small issue about execution of my orders through traddingview it is a bit slow. But the execution of orders directly from the App or Website is absolutely fast and apart from that everything is simple incredible.


Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading